Evidence map›Paper›PMID 30376582›Full record

ArticlePLoS pathogens2018

Hypermutation-induced in vivo oxidative stress resistance enhances Vibrio cholerae host adaptation.

Hui Wang, Xiaolin Xing, Jipeng Wang, Bo Pang, Ming Liu, Jessie Larios-Valencia, Tao Liu, Ge Liu, Saijun Xie, Guijuan Hao and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Stress adaptation underMicrobiology spectrum · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Intestinal colonization againstAIMS microbiology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Microbiota-Associated Biofilm Regulation Leads toFrontiers in cellular and infection microbiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Hui WangDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.ORCID 0000-0001-8865-3599
Xiaolin XingDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.
Jipeng WangDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.
Bo PangState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Ming LiuDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.
Jessie Larios-ValenciaDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America.
Tao LiuDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.
Ge LiuDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.
Saijun XieDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.
Guijuan HaoDepartment of Microbiology, Nanjing Agricultural University, Nanjing, China.
Zhi LiuDepartment of Biotechnology, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0002-8695-9276
Biao KanState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jun ZhuDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America.ORCID 0000-0001-9182-5224
Nanjing Agricultural University · CNNational Institute for Communicable Disease Control and Prevention · CNUniversity of Pennsylvania · USHuazhong University of Science and Technology · CN

Funding

ROS responses during Vibrio cholerae infectionR01AI120489 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ZHU, JUN · 2016 to 2020
$2.4M
NIAID NIH HHS R01 AI120489
6 · The paper itself

Abstract

Bacterial pathogens are highly adaptable organisms, a quality that enables them to overcome changing hostile environments. For example, Vibrio cholerae, the causative agent of cholera, is able to colonize host small intestines and combat host-produced reactive oxygen species (ROS) during infection. To dissect the molecular mechanisms utilized by V. cholerae to overcome ROS in vivo, we performed a whole-genome transposon sequencing analysis (Tn-seq) by comparing gene requirements for colonization using adult mice with and without the treatment of the antioxidant, N-acetyl cysteine. We found that mutants of the methyl-directed mismatch repair (MMR) system, such as MutS, displayed significant colonization advantages in untreated, ROS-rich mice, but not in NAC-treated mice. Further analyses suggest that the accumulation of both catalase-overproducing mutants and rugose colony variants in NAC- mice was the leading cause of mutS mutant enrichment caused by oxidative stress during infection. We also found that rugose variants could revert back to smooth colonies upon aerobic, in vitro culture. Additionally, the mutation rate of wildtype colonized in NAC- mice was significantly higher than that in NAC+ mice. Taken together, these findings support a paradigm in which V. cholerae employs a temporal adaptive strategy to battle ROS during infection, resulting in enriched phenotypes. Moreover, ΔmutS passage and complementation can be used to model hypermuation in diverse pathogens to identify novel stress resistance mechanisms.

Indexed as

Host-Pathogen InteractionsMutationOxidative StressAdaptation, PhysiologicalAnimalsBiofilmsCatalaseCholeraIntestinesMiceReactive Oxygen SpeciesVibrio choleraeVirulenceCatalaseReactive Oxygen Species

Identifiers

PMID30376582
PMCPMC6226196
OpenAlexW2898769770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.